Focus: Larimar Therapeutics is a small-molecule biotech focused on neurology, based in Bala Cynwyd, PA, with early-stage programs targeting rare neurological diseases.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
A high-risk, high-learning opportunity suited to early-career scientists seeking hands-on rare-disease drug development; unsuitable for those prioritizing stability or near-term revenue growth.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Larimar Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Larimar Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles